PRELIMINARY PROGRAM of Main Congress (February 8-11) Suject to change
MSS - MAIN SCIENTIFIC SESSIONS HPV and pregnancy
Chairs: K. Louvanto (Finland) • E. Siegler (Israel)
Wednesday, February 8
Room 0B
8.30 • 10.00
This session will focus on the most common concerns that women in childbearing age have on HPV infection and its consequences. The session will cover the current knowledge on the HPV role in reproductive life, during pregnancy and in children. We will also have a round table discussion on HSIL treatment options for pregnant women.
Coffee Break
Prognostic biomarkers for cervical HSIL progression Chairs: K. Louvanto (Finland) • B. Nedjai (UK)
10.00 • 10.30
Room 0B
10.30 • 12.00
This session will highlight strategies that could identify women with a progressive precancer cervical lesion to immediate referral to colposcopy compared to follow-up testing of women with intermediate risk. These strategies are needed to maximize the benefits of cervical cancer screening and follow-up testing while decreasing the potential harm as cost of unnecessary colposcopy referrals and treatments.
Lunch Break
New guidelines for validation of HPV tests for cervical cancer screening Chairs: M. Arbyn (Belgium) • M. Poljak (Slovenia)
Coffee Break
Monitoring HPV vaccine impact in males (including in MSM programmes -data in these are picking up) Chairs: A. Giuliano (USA) • J. Palefsky (USA)
12.00 • 13.30
Room 0B
13.30 • 15.00
15.00 • 15.30
Room 0B
15.30 • 17.00